Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?
Wynendaele, W.; van Oosterom, A.T.
Forum 9(3): 212-221
1999
ISSN/ISBN: 1121-8142 PMID: 10504169 Document Number: 503859
Neoadjuvant chemotherapy refers to the initial systemic treatment for patients who present with localised cancer for whom there is an alternative but less than completely effective local treatment. There are a multiple reasons for the use of neoadjuvant chemotherapy, but, there may be potential disadvantages. Several neoplasms in which neoadjuvant chemotherapy, if effective, can allow less mutilating surgery and neoplasms in which clinical trials indicate an expanding role for neo-adjuvant therapy are discussed.
Document emailed within 1 workday
Related Documents
Li, J-Feng.; Ouyang, T.; Wang, T-Feng.; Lin, B-Yao. 2004: Neoadjuvant chemotherapy for primary breast cancer Zhonghua Zhong Liu Za Zhi 26(8): 493-495Kubota, T.; Choda, Y.; Morito, T.; Miyake, S.; Ishida, M.; Sato, D.; Sumitani, D.; Nakano, K.; Harano, M.; Matsukawa, H.; Ojima, Y.; Idani, H.; Shiozaki, S.; Okajima, M. 2017: A Case of Duodenal Invasive Advanced Gastric Cancer in which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 1470-1472
Gasowska-Bodnar, A.; Bodnar, L.; Wcisło, G.B.; Jerzak, M.łg.M.; Szczylik, C.; Baranowski, W.ło. 2008: CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction Ginekologia Polska 79(2): 108-114
Niu, Z.-H.; Wang, Y.; Chun, B.; Li, C.-X.; Wu, L. 2013: Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer European Review for Medical and Pharmacological Sciences 17(10): 1337-1344
Cui, J.; Yang, L.; Guo, L.; Shao, Y.; Li, N.; Zhang, H. 2015: Surgical management of patients with pathologic complete response in the primary tumor after neoadjuvant chemotherapy for rectal cancer Zhonghua Zhong Liu Za Zhi 37(6): 456-460
Brain, E.G. 2000: Neoadjuvant chemotherapy in the treatment of breast cancer Annales de Medecine Interne 151(3): 215-219
Lehoczky, O.ó 2005: Neoadjuvant chemotherapy in the treatment of ovarian cancer Orvosi Hetilap 146(38): 1951-1955
Marzetti, L.; Framarino Dei Malatesta, M.; Yacoub, M.; Veneziano, M.; Bandiera, A.F.; Fiorelli, C.; Felici, A. 1997: Neoadjuvant chemotherapy in the treatment of breast cancer. Results and prospectives Minerva Ginecologica 49(9): 393-397
Gadducci, A.; Cosio, S.; Cionini, L.; Genazzani, A.R. 2001: Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of advanced cervical cancer Anticancer Research 21(5): 3525-3533
Mizuno, K.; Kidokoro, K.; Miyazaki, K.; Yoshida, K.; Nakagawa, A.; Mizuno, M.; Suzuki, S.; Kuno, N.; Furuhashi, M.; Ishizuka, T.; Ishikawa, K. 2005: Neoadjuvant chemotherapy with intra-arterial infusion in the treatment of advanced cervical cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(6): 815-819
Terashima, T.; Kawamoto, S.; Maekawa, K.; Kuroki, N. 2017: A Successful Treatment for Stage IIi c Gastric Cancer with Low Cardiac Function Using S-1 plus Oxaliplatin(SOX)as a Neoadjuvant Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 1892-1894
Takatsuka, Y.; Shin, E.; Kikkawa, N. 1996: A clinical trial of neoadjuvant intraarterial chemotherapy for the treatment of locally advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(11): 1523-1525
Kato, M.; Kinoshita, K.; Sawa, T.; Yoshimitsu, S.; Tomita, F.; Takano, Y.; Segawa, M.; Ohyama, S.; Yonemura, Y.; Miwa, K. 1990: Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Part 1): 391-396
Bacci, G.; Picci, P.; Gherlinzoni, F.; Van Horn, J.R.; Orlandi, M.; Normand, A.R.; Manfrini, M.; Pignatti, G.; Campanacci, M. 1986: Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(2): 140-143
Ivanov, S.; Kovachev, E.; Kolev, N.; Bechev, B.; Kolev, N. 2016: Primary Cytoreductive Surgery versus Neoadjuvant Chemotherary in Treatment of Advanced Ovarian Cancer (Stage Iii C-Iv). our and Foreign Experience Akusherstvo i Ginekologiia 55 Suppl 1 Pt 1: 16-19
Sadahiro, S.; Tanaka, A. 2011: Advantage of oral administration for chemotherapy of colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(11): 1798-1802
Katayose, Y.; Nakagawa, K.; Onogawa, T.; Yoshida, H.; Motoi, F.; Naitoh, T.; Rikiyama, T.; Egawa, S.; Unno, M. 2011: A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2651-2653
Ychou, M. 1995: Is neoadjuvant chemotherapy necessary in cancer of the stomach? Annales de Gastroenterologie et d'Hepatologie 31(2): 132-133
Onda, T. 2012: Neoadjuvant chemotherapy for ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(6): 882-886
Camci, C.; Balat, O. 2002: Neoadjuvant chemotherapy in ovarian cancer European Journal of Gynaecological Oncology 23(5): 437-441